Market Cap : 388.99 M | Enterprise Value : 361.71 M | PE Ratio : 15.30 | PB Ratio : 7.72 |
---|
NAS:CODX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CODX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Co-Diagnostics's share price for the quarter that ended in Sep. 2020 was $13.59. Co-Diagnostics's Shares Outstanding (EOP) for the quarter that ended in Sep. 2020 was 29.60 Mil. Therefore, Co-Diagnostics's market cap for the quarter that ended in Sep. 2020 was $402.24 Mil.
Co-Diagnostics's quarterly market cap increased from Mar. 2020 ($209.18 Mil) to Jun. 2020 ($541.63 Mil) but then declined from Jun. 2020 ($541.63 Mil) to Sep. 2020 ($402.24 Mil).
Co-Diagnostics's annual market cap declined from Dec. 2017 ($32.52 Mil) to Dec. 2018 ($19.26 Mil) and declined from Dec. 2018 ($19.26 Mil) to Dec. 2019 ($15.61 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Co-Diagnostics's Enterprise Value for Today is $361.71 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Co-Diagnostics's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Co-Diagnostics's Market Cap for the fiscal year that ended in Dec. 2019 is calculated as
Market Cap (A: Dec. 2019 ) | = | Share Price (A: Dec. 2019 ) | * | Shares Outstanding (EOP) (A: Dec. 2019 ) |
= | $0.9 | * | 17.3429 | |
= | $15.61 |
Co-Diagnostics's Market Cap for the quarter that ended in Sep. 2020 is calculated as
Market Cap (Q: Sep. 2020 ) | = | Share Price (Q: Sep. 2020 ) | * | Shares Outstanding (EOP) (Q: Sep. 2020 ) |
= | $13.59 | * | 29.598 | |
= | $402.24 |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
No Headline